About This Report
This new report presents detailed analysis of the U.K. STD market.
Current scientific views on epidemiology and etiology are presented for:
- AIDS/HIV
- Chancroid
- Chlamydia
- Gonorrhea
- Granuloma Inguinale
- Herpes I/II
- Lymphogranuloma
- Mycoplasma
- Papillomavirus
- Syphilis
- Trichomonas Vaginalis
The report provides test volume and sales projections for:
- Hospitals
- Commercial/Private Labs
- Public Health Labs
The report is available by section, and can be customized to specific information needs and budget.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.
